1. Home
  2. AUPH vs CASH Comparison

AUPH vs CASH Comparison

Compare AUPH & CASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

N/A

Current Price

$15.83

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Logo Pathward Financial Inc.

CASH

Pathward Financial Inc.

N/A

Current Price

$73.52

Market Cap

1.7B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
AUPH
CASH
Founded
1993
1954
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
AUPH
CASH
Price
$15.83
$73.52
Analyst Decision
Buy
Buy
Analyst Count
4
2
Target Price
$17.25
$91.00
AVG Volume (30 Days)
1.5M
219.8K
Earning Date
11-04-2025
01-20-2026
Dividend Yield
N/A
0.27%
EPS Growth
N/A
9.29
EPS
0.55
7.87
Revenue
$265,808,000.00
$780,120,000.00
Revenue This Year
$21.22
$10.95
Revenue Next Year
$15.40
$4.75
P/E Ratio
$28.70
$9.30
Revenue Growth
20.62
5.66
52 Week Low
$6.55
$64.45
52 Week High
$16.48
$86.00

Technical Indicators

Market Signals
Indicator
AUPH
CASH
Relative Strength Index (RSI) 58.50 53.83
Support Level $15.57 $72.63
Resistance Level $16.07 $76.17
Average True Range (ATR) 0.49 1.82
MACD -0.10 0.08
Stochastic Oscillator 66.17 40.04

Price Performance

Historical Comparison
AUPH
CASH

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

Share on Social Networks: